SciELO - Scientific Electronic Library Online

 
vol.14 número6Molecular detection of cytomegalovirus, herpes simplex virus 2, human papillomavirus 16-18 in Turkish pregnantsTyphidot M and Diazo test vis-à-vis blood culture and Widal test in the early diagnosis of typhoid fever in children in a resource poor setting índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Brazilian Journal of Infectious Diseases

versão impressa ISSN 1413-8670

Resumo

SPRINZ, Eduardo; LAZZARETTI, Rosmeri Kuhmmer; KUHMMER, Regina  e  RIBEIRO, Jorge Pinto. Dyslipidemia in HIV-infected individuals. Braz J Infect Dis [online]. 2010, vol.14, n.6, pp. 575-588. ISSN 1413-8670.  http://dx.doi.org/10.1590/S1413-86702010000600006.

Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidemia associated with HIV infection and with the use of combined antiretroviral therapy includes elevations in triglycerides, reduced high-density cholesterol, and variable increases in low-density and total cholesterol. The association between dyslipidemia and specific antiretroviral agents has been underscored. Multiple pathogenic mechanisms by which HIV and antiretroviral agents lead to dyslipidemia have been hypothesized, but they are still controversial. The potential clinical and pathological consequences of HIV-associated hyperlipidemia are not completely known, but several studies reported an increased risk of coronary artery disease in HIV-positive individuals receiving combined antiretroviral therapy. HIV-infected persons who have hyperlipidemia should be managed similarly to those without HIV infection in accordance with the National Cholesterol Education Program. Life style changes are the primary target. Statins and fibrates and/or modification in antiretroviral therapy are possible approaches to this problem.

Palavras-chave : HIV/AIDS; dyslipidemia; combined antiretroviral therapy; nutrition; Public Health.

        · texto em Inglês     · pdf em Inglês